Trujillo TC - Search Results

1

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding.

Stevens VM, Trujillo TC, Kiser TH, MacLaren R, Reynolds PM, Mueller SW. Stevens VM, et al. Among authors: trujillo tc. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211039020. doi: 10.1177/10760296211039020. Clin Appl Thromb Hemost. 2021. PMID: 34541920 Free PMC article.

2

Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.

Kiser TH, Mann AM, Trujillo TC, Hassell KL. Kiser TH, et al. Among authors: trujillo tc. Am J Hematol. 2011 Mar;86(3):267-72. doi: 10.1002/ajh.21955. Epub 2011 Feb 15. Am J Hematol. 2011. PMID: 21328434 Free article. Clinical Trial.

3

Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples.

Lind SE, Boyle ME, Fisher S, Ishimoto J, Trujillo TC, Kiser TH. Lind SE, et al. Among authors: trujillo tc. Am J Clin Pathol. 2014 May;141(5):665-74. doi: 10.1309/AJCPGTCEX7K4GXQO. Am J Clin Pathol. 2014. PMID: 24713737

4

The role of prothrombin complex concentrates in reversal of target specific anticoagulants.

Babilonia K, Trujillo T. Babilonia K, et al. Thromb J. 2014 Apr 17;12:8. doi: 10.1186/1477-9560-12-8. eCollection 2014. Thromb J. 2014. PMID: 24742134 Free PMC article. Review.

5

Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization.

Babilonia KM, Golightly LK, Gutman JA, Hassell KL, Kaiser JN, Kiser TH, Klem PM, Trujillo TC. Babilonia KM, et al. Among authors: trujillo tc. Clin Appl Thromb Hemost. 2014 Nov;20(8):799-806. doi: 10.1177/1076029614543140. Epub 2014 Jul 14. Clin Appl Thromb Hemost. 2014. PMID: 25022565 Free article.

6

Evaluation of a Heparin-Calibrated Antifactor Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors.

Beyer J, Trujillo T, Fisher S, Ko A, Lind SE, Kiser TH. Beyer J, et al. Clin Appl Thromb Hemost. 2016 Jul;22(5):423-8. doi: 10.1177/1076029616629759. Epub 2016 Feb 2. Clin Appl Thromb Hemost. 2016. PMID: 26842561 Free article.

7

Reversal agents for use with direct and indirect anticoagulants.

Smythe MA, Trujillo T, Fanikos J. Smythe MA, et al. Am J Health Syst Pharm. 2016 May 15;73(10 Suppl 2):S27-48. doi: 10.2146/ajhp150959. Am J Health Syst Pharm. 2016. PMID: 27147456 Review.

8

Antidotes for reversal of direct oral anticoagulants.

Dobesh PP, Bhatt SH, Trujillo TC, Glaubius K. Dobesh PP, et al. Among authors: trujillo tc. Pharmacol Ther. 2019 Dec;204:107405. doi: 10.1016/j.pharmthera.2019.107405. Epub 2019 Sep 12. Pharmacol Ther. 2019. PMID: 31521696 Review.

9

Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients.

Beyer JT, Lind SE, Fisher S, Trujillo TC, Wempe MF, Kiser TH. Beyer JT, et al. Among authors: trujillo tc. J Thromb Thrombolysis. 2020 Feb;49(2):259-267. doi: 10.1007/s11239-019-01961-3. J Thromb Thrombolysis. 2020. PMID: 31559512

10

Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center.

Stevens VM, Trujillo T, Mueller SW, MacLaren R, Reynolds PM, Kiser TH. Stevens VM, et al. Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619896619. doi: 10.1177/1076029619896619. Clin Appl Thromb Hemost. 2019. PMID: 31876159 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page